Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Mature T-cell leukemias Ravandi F; Kantarjian H; Jones D; Dearden C; Keating M; O'Brien SCancer 2005[Nov]; 104 (9): 1808-18Mature T-cell and NK-cell leukemias are a group of relatively uncommon neoplasms derived from mature or postthymic T-cells accounting for a relatively small percentage of lymphoid malignancies. The recent availability of modern immunophenotypic and molecular tools has allowed a better distinction of these disorders from their B-cell counterparts. Similarly, identification of recurrent cytogenetic abnormalities, as well as plausible mechanisms through which these molecular events influence cellular signaling pathways, have created further insight into the pathogenesis of these disorders. Furthermore, the availability of new agents such as alemtuzumab has generated significant interest in devising specific therapeutic strategies for these malignancies. Herein, we review the clinical and pathological features of mature T-cell leukemias.|Adult[MESH]|Alemtuzumab[MESH]|Antibodies, Monoclonal, Humanized[MESH]|Antibodies, Monoclonal/therapeutic use[MESH]|Antibodies, Neoplasm/therapeutic use[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Human T-lymphotropic virus 1[MESH]|Humans[MESH]|Immunophenotyping[MESH]|Leukemia, Lymphoid[MESH]|Leukemia, Prolymphocytic/diagnosis/drug therapy/genetics[MESH]|Leukemia, T-Cell/blood/*diagnosis/drug therapy/genetics[MESH]|Leukemia-Lymphoma, Adult T-Cell/diagnosis/drug therapy/genetics/virology[MESH]|Middle Aged[MESH]|Tumor Virus Infections[MESH] |
